✦ LIBER ✦

P.090 Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)

✍ Scribed by R.A. De Man; D. Mutimer; R. Gish; T. Chang; J. Zhu; A. Cross; H. Brett-Smith

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.082 Entecavir (ETV) treatment through

✍ M. Manns; D. Shouval; U.S. Akarca; G. Hatzis; G. Kitis; R. Zink; J. Zhu; H. Bret 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

80 Entecavir results in continued virolo

✍ C. Yurdaydin; J. Sollano; S. Hadziyannis; S. Kaymakoglu; M. Sherman; H. Brett-Sm 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 102 KB

O.183 Entecavir results in continued vir

✍ C. Yurdaydin; J. Sollano; S. Hadziyannis; S. Kaymakoglu; M. Sherman; H. Brett-Sm 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

45 Continued virologic and biochemical i

✍ D. Shouval; U.S. Akarca; G. Hatzis; G. Kitis; C.L. Lai; H. Cheinquer; T.T. Chang 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 239 KB

633 Histologic Improvement in Asian Pati

✍ Tong, Myron J.; Chang, Ting-Tsung; Wu, Shun-Sheng; Han, Kwang-Hyub; Yoon, Seung 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 106 KB